GE HEALTHCARE TECH.INC. (L0T) — Capital Reinvestment Ratio

Latest as of March 2026: 0.61x

GE HEALTHCARE TECH.INC. (L0T) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow (€290.00 Million) in capital expenditures (€178.00 Million). Check L0T intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.61x
Capex / Operating Cash Flow

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

Data as of

Mar 2026
Most recent filing

GE HEALTHCARE TECH.INC. Capital Reinvestment Ratio (2022–2025)

This chart tracks GE HEALTHCARE TECH.INC.'s Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see GE HEALTHCARE TECH.INC. cash flow conversion.

Annual Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. (2022–2025)

Year-by-year Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. from 2022 to 2025. See how much free cash does GE HEALTHCARE TECH.INC. generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.24x €1.99 Billion €482.00 Million ▲ +18.0%
2024 0.21x €1.95 Billion €401.00 Million ▲ +11.6%
2023 0.18x €2.10 Billion €387.00 Million ▲ +25.6%
2022 0.15x €2.11 Billion €310.00 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow